68 results
8-K
EX-10.1
w12gc m78
28 Sep 23
Entry into a Material Definitive Agreement
4:50pm
8-K/A
EX-10.1
kvjyu
22 Aug 23
Departure of Directors or Certain Officers
8:30am
8-K
EX-99.1
nxr5kc
9 Aug 23
Agile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
8:10am
S-8
EX-99.1
es2x9oj
9 Jun 23
Registration of securities for employees
5:19pm
8-K
EX-99.1
8jg xbanb0
11 May 23
Agile Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:15pm
8-K
EX-99.1
nslzwcb d15xszlrrywf
7 Nov 22
Agile Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
EX-99.1
w0vfnx
11 Aug 22
Agile Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
424B4
43b39
5 Jul 22
Prospectus supplement with pricing info
4:26pm
424B5
tqyis2v5h9jkc8 dz
27 Apr 22
Prospectus supplement for primary offering
6:30am